Reduced plasma transforming growth factor-β1 levels in patients with chronic hepatitis C after interferon-α therapy: association with regression of hepatic fibrosis
- 1 January 1999
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 30 (1), 1-7
- https://doi.org/10.1016/s0168-8278(99)80001-4
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Changes in Serum Fibrogenesis Markers During Interferon Therapy for Chronic Hepatitis Type CHepatology, 1996
- Plasma transforming growth factor-? (TGF-?) levels in hepatic fibrosis Duke University Medical Center, Durham, NC, Department of Medicine, *Department of Pathology, #Department of Radiation OncologyHepatology, 1995
- Quantitative analysis of transforming growth factor β1 messenger RNA in the liver of patients with chronic hepatitis C: Absence of correlation between high levels and severity of diseaseHepatology, 1995
- Modulation of Collagen Synthesis and Degradation by Retinoids and Cytokines in 3T3 L1 Preadipocytes.Internal Medicine, 1994
- Transforming Growth Factors β1 and α in Chronic Liver DiseaseNew England Journal of Medicine, 1991
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Liver fibrosis and extracellular matrixJournal of Hepatology, 1989
- Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha InterferonNew England Journal of Medicine, 1986
- Selective inhibition of human diploid fibroblast collagen synthesis by interferons.Journal of Clinical Investigation, 1984